Effects of Metformin on Proliferation and Differentiation of Bone Marrow Stromal Cells in Osteoblastic Medium

Zhang Haibo,Liang Weizhi,Gao Ying,Hu Jing

DOI: https://doi.org/10.3969/j.issn.1673-548X.2011.10.043

2011-01-01

Abstract:Objective To investigate the possible effects of metformin,a commonly used drug for the patients with type 2 diabetes,on the proliferation and differentiation of rat bone marrow stromal cells(BMSCs) cultured in osteoblatic medium.Methods The BMSCs used in this study were isolated from the femurs and tibias of Sprague-Dawley rats and then cultured in the osteoblatic medium with or without 100μmol/L metformin.MTT assay was performed to evaluate the proliferation of the cells cultured in osteoblastic medium with or without metformin,while alkaline phosphate(ALP) activities analysis and mineralization nodules assessment were performed to evaluate the osteoblastic differentiation of these cells.At last,real time RT-PCR was further performed to quantify the mRNA expression levels of osteoblastic marker genes in osteoblastic differentiation cells treated with or without metformin.Results The number of BMSCs in two groups both increased over time,and metformin induced more cells.By contrast,the cells affected by metformin showed higher ALP activities,more nodules in the culture and more calcium deposition in mineralized nodules,as examined by ARS staining.The optical density of ARS destaining solution in metformin group was significantly higher than that of control group.Moreover,the promotive effects of metformin on osteoblastic differentiation were further examined by testing the mRNA levels of osteoblastic marker genes using real-time RT-PCR.The metformin-containing medium yielded higher levels of mRNA levels for osteoblastic markers.Conclusion Metformin may promote the proliferation and differentiation of BMSCs cultured in osteoblastic medium.